Aug 29, 2016 ... BRACY ANDERSON et al., ... Bristol-Myers Squibb Company (BMS), a pharmaceutical .... 754]; Goodyear Dunlop Tires Operations, S.A. v.
Parties, docket activity and news coverage of federal case Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc., case number 1:17-cv-00379, from ...
Jan 13, 2016 ... v. Bristol-Myers Squibb Company,. Otsuka Pharmaceutical Co., Ltd., and ..... 28 Eric Hollander et al.., Pathological Gambling, 23(3) THE PSYCHIATRIC .... Cochrane Database of Systematic Reviews, THE COCHRANE ...
Oct 27, 2017 ... Relators, former BMS employees, alleged in a qui tam suit that BMS and Otsuka engaged in a ... Relators allege that, despite those agreements, the companies continued to ... Ibanez v. Bristol-Myers Squibb Co., No. 16-3154 (6th Cir. 2017) ... 16-3154 U.S. ex rel. Ibanez v. Bristol-Myers Squibb, et. al. Page 2 ...
Jun 19, 2017 ... OF CALIFORNIA, SAN FRANCISCO COUNTY, ET AL. CERTIORARI TO ... Bristol -Myers Squibb Company (BMS) in California state court, al-.
Feb 7, 2019 ... ImmunoGen, Inc.; E. I. du Pont de Nemours & Co. v. ... Momenta Pharmaceuticals , Inc. v, Bristol-Myers Squibb Co. (Fed. ... The case involved a inter partes review ( IPR) brought by Momenta against all claims of U.S. Patent No.
All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care ..... Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients ...... Bethesda (MD): Eli Lilly & Company and the National Center for Advancing ...... in patients with impaired renal function: response to Hellfritzsch et al.